KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Medpace Holdings (MEDP) over the last 9 years, with Q4 2025 value amounting to $12.2 million.

  • Medpace Holdings' Treasury Shares fell 64.57% to $12.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.2 million, marking a year-over-year decrease of 64.57%. This contributed to the annual value of $12.2 million for FY2025, which is 64.57% down from last year.
  • Medpace Holdings' Treasury Shares amounted to $69623.0 in Q4 2025, which was down 64.22% from $70073.0 recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Treasury Shares ranged from a high of $602187.0 in Q4 2021 and a low of $69623.0 during Q4 2025
  • Moreover, its 5-year median value for Treasury Shares was $70573.0 (2023), whereas its average is $154406.7.
  • As far as peak fluctuations go, Medpace Holdings' Treasury Shares soared by 15534.24% in 2022, and later tumbled by 1348.73% in 2023.
  • Over the past 5 years, Medpace Holdings' Treasury Shares (Quarter) stood at $5.4 million in 2021, then soared by 130.27% to $12.5 million in 2022, then decreased by 1.4% to $12.3 million in 2023, then decreased by 0.71% to $12.2 million in 2024, then decreased by 0.65% to $12.2 million in 2025.
  • Its Treasury Shares was $12.2 million in Q4 2025, compared to $12.2 million in Q3 2025 and $12.2 million in Q2 2025.